Namenda Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Optimizing Neurocognition With Whole Brain Radiation Therapy (WBRT) Using Upfront Pulsed Reduced Dose-Rate (uPRDR) Technique
Condition:   Brain Metastases Interventions:   Drug: Memantine -Twice Daily ≥30 creatinine clearance.;   Radiation: WBRT utilizing the PRDR technique;   Drug: Memantine Extended Release Creatinine Clearance ≥30;   Drug: Memantine -Twice Daily ≥5-29 CrCl;   Drug: Memantine Extended Release ≥5-29 CrCl Creatinine Clearance ;   Drug: Memantine -Twice Daily  (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 16, 2021 Category: Research Source Type: clinical trials

Memantine for Refractory OCD Patients
Condition:   Obsessive-Compulsive Disorder Interventions:   Drug: Memantine Oral Tablet;   Drug: Placebo Sponsor:   University of Roma La Sapienza Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 20, 2021 Category: Research Source Type: clinical trials